Thrombotic thrombocytopenic purpura screening
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombotic thrombocytopenic purpura screening On the Web |
|
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura screening |
|
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is no insufficient evidence to recommend routine screening for TTP.[1]
First test to be screening for ADAMTS13 activity.[1]ADAMTS13 activity < 10%, TTP diagnosis is confirmed.
In sever deficiency of ADAMTS13 second screening is detection of anti-ADAMTS13 IgG
Gene sequencing of DAMTS13 is a third test is used.